Jin Wook (miles) Suk - 25 Jul 2025 Form 4 Insider Report for Abpro Holdings, Inc. (ABP)

Role: CEO and Chairman, Director
Signature: /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Issuer symbol: ABP
Transactions as of: 25 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 29 Jul 2025, 08:42:37 UTC
Previous filing: 19 May 2025
Next filing: 04 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Suk Jin Wook (Miles)	CEO and Chairman, Director	C/O ABPRO HOLDINGS, INC., 68 CUMMINGS PARK DRIVE, WOBURN	/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact	29 Jul 2025	0002044498

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABP	Common Stock, par value $0.0001 per share	Award	$0	+500,000	+341%	$0.000000	646,477	25 Jul 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.0001 per share, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2024 Equity Incentive Plan. The 500,000 RSUs included in Column 5 of Table I vest in three equal annual installments on each anniversary of March 3, 2025, subject to BioCelsus International Inc.'s (the "Consultant") service continuing through and on each such vesting date. The RSUs were issued to the reporting person as the designee of the Consultant.

Content

Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.0001 per share, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2024 Equity Incentive Plan. The 500,000 RSUs included in Column 5 of Table I vest in three equal annual installments on each anniversary of March 3, 2025, subject to BioCelsus International Inc.'s (the "Consultant") service continuing through and on each such vesting date. The RSUs were issued to the reporting person as the designee of the Consultant.